Virax Biolabs Group's chart data is dated 2026-10-08. There is no active technical signal. There are 0 published signal records.
Virax Biolabs Group last closed at $1.99 (-5.69%) on 2026-10-08. Listed on Nasdaq. Trailing 12 months PER is -0.1×. Its overall grade ranks 697 of 738 stocks in Healthcare.
About this company
Virax Biolabs Group last closed at $1.99 (-5.69%) on 2026-10-08. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall F · 697/738
Valuation grade D
Related stocks
- Abbott LaboratoriesCompetitor
감염병·진단 검사 분야의 대형 경쟁사
- RocheCompetitor
분자진단·체외진단(IVD)에서 글로벌 경쟁사
- Thermo Fisher ScientificCompetitor
분자진단 시약·장비 및 연구용 진단 솔루션 경쟁
About Virax Biolabs Group
- What technical signals does Virax Biolabs Group (VRAX) have?
- Virax Biolabs Group current technical signals: no active technical signal.
- Is Virax Biolabs Group a cup-and-handle pattern?
- No. Virax Biolabs Group has no valid Cup signal right now.
- What published figures are available for Virax Biolabs Group?
- Market cap: $0.52M. Trailing 12 months PER: -0.1×. Latest quarter PBR: 0.11×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Virax Biolabs Group, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.